Zelira Therapeutics Limited (ZLDAF) has a market capitalization of $3.91M and trades at $0.33. The 52-week range is 0.2-0.4165.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-0.32, annual revenue of $656.00.
The stock has a beta of 0.63, operates in the Healthcare sector.
